在ALS中微结构性脑退化的时间和空间进展:一个多中心纵向扩散张力成像研究
Hans-Peter Müller1, Agessandro Abrahao2, Christian Beaulieu3
1Department of Neurology, University of Ulm, Ulm, Germany.
NeuroImage. Clinical
|June 18, 2024
概括
扩散张力成像 (DTI) 揭示了肌皮管 (CST) 在肌缩侧面硬化症 (ALS) 中逐渐白质变化. 沿着CST的微分异位性 (FA) 作为可靠的纵向生物标志物,用于跟踪ALS进展.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 生物标志物发现发现
背景情况:
- 肌缩侧面硬化症 (ALS) 的特征是逐渐的神经退行.
- 皮质脊髓管 (CST) 在ALS中受到显著影响.
- 扩散张力成像 (DTI) 可以检测白质中的微观结构变化.
研究的目的:
- 为了评估沿着CST的微分异型性 (FA),作为ALS疾病进展的纵向标记.
- 在ALS患者中使用DTI评估CST的微观结构变化.
- 确定DTI作为ALS中大脑退化的一个生物标志物.
主要方法:
- 一项纵向的多中心研究 (CALSNIC-2),涉及114名ALS患者和110名健康对照.
- 在7个中心采用协调协议收集DTI和临床数据.
- 使用基于整个大脑的空间统计和兴趣路径方法进行横截面和纵向评估的分析.
主要成果:
- 在ALS患者中,在CST和中体体 (CC) 纵向观察到减少的FA.
- CST和庞丁FA与功能障碍 (ALSFRS-R) 和疾病进展率相关.
- 在FA的纵向下降在下CST最明显,而横截面变化在上CST最大.
结论:
- 在ALS中,渐进的微观结构变化在CST和CC中最为突出.
- DTI为ALS中大脑退化提供了一个可行的生物标志物.
- 在ALS的长度白质变化可以在实践观察期和参与者数量内证明.
相关概念视频
Cross-bridge Cycle
108.6K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
108.6K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
13
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
13
Alzheimer Disease ll: Pathophysiology
16
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
16
Dementia l: Introduction
29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
Secondary Spinal Cord Injury llI: Pathophysiology
34
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
34


